Allan Lawrie Selected Research

Allan Lawrie Research Topics

Disease

31	Pulmonary Arterial Hypertension 03/2024 - 01/2008
13	Pulmonary Hypertension 01/2021 - 08/2005
10	Inflammation (Inflammations) 03/2024 - 01/2008
5	Familial Primary Pulmonary Hypertension 10/2020 - 01/2012
5	Vascular Remodeling 10/2020 - 10/2011
4	Hypoxia (Hypoxemia) 01/2022 - 03/2018
3	Systemic Scleroderma (Systemic Sclerosis) 01/2021 - 01/2018
3	Fibrosis (Cirrhosis) 10/2020 - 09/2012
3	Heart Failure 01/2020 - 12/2014
3	Necrosis 01/2018 - 09/2012
2	COVID-19 12/2023 - 04/2022
2	Ventricular Remodeling 07/2022 - 03/2018
2	Thrombosis (Thrombus) 04/2022 - 01/2022
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 02/2013
2	Hypertrophy 10/2020 - 03/2018
2	Atherosclerosis 01/2018 - 01/2016
2	Chronic Obstructive Pulmonary Disease (COPD) 01/2018 - 06/2013
2	Vascular Diseases (Vascular Disease) 01/2014 - 08/2005
1	Starvation 03/2024
1	Infections 12/2023
1	Respiratory Tract Diseases (Respiratory Tract Disease) 12/2023
1	Connective Tissue Diseases (Connective Tissue Disease) 10/2021
1	Congenital Heart Defects (Congenital Heart Defect) 10/2021
1	Microvascular Rarefaction 10/2020
1	Disease Susceptibility (Diathesis) 01/2020
1	Portal Hypertension 12/2019
1	Fatigue 12/2019
1	Dyspnea (Shortness of Breath) 12/2019
1	Channelopathies 10/2018
1	Rare Diseases (Rare Disease) 11/2017
1	Lymphadenopathy 11/2017
1	Pulmonary Veno-Occlusive Disease (Veno Occlusive Disease, Pulmonary) 11/2017

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 01/2021 - 12/2014
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2018
4	MicroRNAs (MicroRNA)IBA 07/2021 - 02/2013
4	OsteoprotegerinIBA 11/2019 - 01/2008
4	LigandsIBA 01/2018 - 09/2012
4	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 11/2017 - 09/2009
3	ProteomeIBA 01/2022 - 01/2017
3	RNA (Ribonucleic Acid)IBA 10/2020 - 12/2015
3	Carbon MonoxideIBA 01/2018 - 06/2013
2	Eplerenone (Inspra)FDA LinkGeneric 07/2022 - 03/2018
2	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2022 - 10/2020
2	pro-brain natriuretic peptide (1-76)IBA 01/2022 - 10/2020
2	MonocrotalineIBA 10/2020 - 12/2015
2	CytokinesIBA 01/2018 - 01/2015
2	ApolipoproteinsIBA 01/2018 - 10/2011
2	IronIBA 01/2018 - 01/2017
2	Apolipoproteins E (ApoE)IBA 01/2018 - 10/2011
2	Death Domain ReceptorsIBA 01/2018 - 09/2012
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2014 - 10/2012
2	Serotonin (5 Hydroxytryptamine)IBA 01/2008 - 08/2005
1	Proline (L-Proline)FDA Link 03/2024
1	Serine (L-Serine)FDA Link 03/2024
1	Transcription Factors (Transcription Factor)IBA 03/2024
1	Betaine (C.B.B.)FDA Link 03/2024
1	Activating Transcription Factor 4IBA 03/2024
1	XenobioticsIBA 03/2024
1	Cathepsin ZIBA 01/2024
1	ruboxistaurinIBA 04/2022
1	Protein Kinase CIBA 04/2022
1	LipopolysaccharidesIBA 04/2022
1	Oxygen (Dioxygen)IBA 01/2022
1	Cardiovascular AgentsIBA 01/2022
1	P-SelectinIBA 01/2022
1	von Willebrand FactorIBA 01/2022
1	7-(N-(3-aminopropyl)amino)heptan-2-oneIBA 10/2021
1	FrataxinIBA 01/2021
1	navitoclaxIBA 01/2021
1	Chemokine ReceptorsIBA 01/2021
1	ChemokinesIBA 01/2021
1	E2F Transcription FactorsIBA 10/2020
1	Long Noncoding RNAIBA 10/2020
1	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 10/2020
1	Enhancer of Zeste Homolog 2 ProteinIBA 10/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020
1	EndoglinIBA 01/2020
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2020
1	Type II Bone Morphogenetic Protein Receptors (Bone Morphogenetic Protein Receptor Type II)IBA 12/2019
1	Poly I-CIBA 01/2019
1	HLA-DPB1 antigen (HLA DPB1)IBA 01/2019
1	HLA-DPA1 antigen (HLA DPA1)IBA 01/2019
1	Semaxinib (SU5416)IBA 01/2019
1	Toll-Like Receptor 3IBA 01/2019
1	PotassiumIBA 10/2018
1	AldosteroneIBA 03/2018
1	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 03/2018
1	macitentanIBA 01/2018
1	AntigensIBA 01/2018
1	Endothelins (Endothelin)IBA 01/2018
1	prednylidene (Pred)IBA 01/2018
1	Dynamins (Dynamin)IBA 01/2018
1	DNA (Deoxyribonucleic Acid)IBA 11/2017
1	Phosphotransferases (Kinase)IBA 11/2017

Therapy/Procedure

10	Therapeutics 03/2024 - 11/2011
2	Denervation 12/2015 - 11/2015
1	Wearable Electronic Devices 12/2023
1	Ambulatory Care (Outpatient Care) 12/2023
1	Liver Transplantation 12/2019
1	Endarterectomy (Thromboendarterectomy) 01/2018